The Current Ratio as of December 2024 (TTM) for Cabaletta Bio, Inc. (CABA) is 8.11

According to Cabaletta Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.11. This represents a change of -31.83% compared to the average of 11.89 of the last 4 quarters.

Cabaletta Bio, Inc. (CABA) Historical Current Ratio (quarterly & annually)

How has CABA Current Ratio performed in the past?

The mean historical Current Ratio of Cabaletta Bio, Inc. over the last ten years is 20.61. The current 8.11 Current Ratio has changed 3.83% with respect to the historical average. Over the past ten years (40 quarters), CABA's Current Ratio was at its highest in in the December 2019 quarter at 44.66. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Cabaletta Bio, Inc. (CABA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cabaletta Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cabaletta Bio, Inc. (CABA) Average Current Ratio

How has CABA Current Ratio performed in the past?

The current Current Ratio of Cabaletta Bio, Inc. (CABA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cabaletta Bio, Inc. (CABA) Current Ratio vs. Peers

How is CABA’s Current Ratio compared to its peers?

Cabaletta Bio, Inc.’s Current Ratio is less than TCR2 Therapeutics Inc. (0), greater than Revolution Medicines, Inc. (2.77), less than Black Diamond Therapeutics, Inc. (14.24), greater than Atreca, Inc. (5.55), greater than Passage Bio, Inc. (1.58), greater than 89bio, Inc. (5.15), less than Madrigal Pharmaceuticals, Inc. (11.66), greater than Pliant Therapeutics, Inc. (5.98), less than Arcellx, Inc. (10.26), greater than Stoke Therapeutics, Inc. (4.29), greater than Harpoon Therapeutics, Inc. (5.09), greater than Alector, Inc. (1.89), greater than Larimar Therapeutics, Inc. (3.29), less than Homology Medicines, Inc. (13.10), greater than Day One Biopharmaceuticals, Inc. (4.19), less than null (14.62),

Build a custom stock screener for Cabaletta Bio, Inc. (CABA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabaletta Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cabaletta Bio, Inc. (CABA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cabaletta Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.